Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Imiquimod finds multiple roles in perioperative skin cancer cases
Stanford, Calif. - Topical imiquimod 5 percent cream (Aldara, 3M) can be a valuable adjunct in skin cancer surgery, said Todd S. Anhalt, M.D., at "The Next Step: Mastering Cutaneous Outpatient Procedures," a continuing education program sponsored by the Stanford University department of dermatology.
Recent Videos
Related Content
